Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: The OAKTREE Study

Conference Reports for NATAP

ID Week 2024
October 16-19
Los Angeles, California


Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: The OAKTREE Study

	DWeek; October 16-19, 2024; Los Angeles, CA, USA